Scholars@Duke publication: The role of 1,25-dihydroxycholecalciferol (DHCC) in the pathogenesis and treatment of X-linked hypophosphatemic rickets (XLH)

The role of 1,25-dihydroxycholecalciferol (DHCC) in the pathogenesis and treatment of X-linked hypophosphatemic rickets (XLH)

Publication , Journal Article

Drezner, MK; Haussler, MR; Lyles, KW; Harrelson, JM

Published in: Clinical Research

January 1, 1979

Duke Scholars

Author Kenneth Ward Lyles Medicine, Geriatrics

John Miles Harrelson

Author John Miles Harrelson Orthopaedic Surgery

Published In

Clinical Research

ISSN

0009-9279

Publication Date

January 1, 1979

Volume

27

Issue

2

Citation

APA

Chicago

ICMJE

MLA

NLM

Drezner, M. K., Haussler, M. R., Lyles, K. W., & Harrelson, J. M. (1979). The role of 1,25-dihydroxycholecalciferol (DHCC) in the pathogenesis and treatment of X-linked hypophosphatemic rickets (XLH). Clinical Research, 27(2).

Drezner, M. K., M. R. Haussler, K. W. Lyles, and J. M. Harrelson. “The role of 1,25-dihydroxycholecalciferol (DHCC) in the pathogenesis and treatment of X-linked hypophosphatemic rickets (XLH).” Clinical Research 27, no. 2 (January 1, 1979).

Drezner MK, Haussler MR, Lyles KW, Harrelson JM. The role of 1,25-dihydroxycholecalciferol (DHCC) in the pathogenesis and treatment of X-linked hypophosphatemic rickets (XLH). Clinical Research. 1979 Jan 1;27(2).

Drezner, M. K., et al. “The role of 1,25-dihydroxycholecalciferol (DHCC) in the pathogenesis and treatment of X-linked hypophosphatemic rickets (XLH).” Clinical Research, vol. 27, no. 2, Jan. 1979.

Drezner MK, Haussler MR, Lyles KW, Harrelson JM. The role of 1,25-dihydroxycholecalciferol (DHCC) in the pathogenesis and treatment of X-linked hypophosphatemic rickets (XLH). Clinical Research. 1979 Jan 1;27(2).

Published In

Clinical Research

ISSN

0009-9279

Publication Date

January 1, 1979

Volume

27

Issue

2